Week ending Friday, October 17, 2026 · Published by QuantLogix Research
A volatile tape ended with the Nasdaq posting its worst week since late June as AI–adjacent names cracked under financing scrutiny and a hotter-than-expected September CPI print. Defensive rotation lifted the Dow to a weekly gain while gold and silver tagged fresh records.
Levels are approximate end-of-week prints; weekly % tracks Friday-to-Friday close. Nasdaq's draw was the worst since the week ended June 27 and ended a month-long winning streak.
Classic risk-off dispersion: health care at record highs, financials buoyed by trading desks, energy riding a Hormuz-driven oil bid. Technology took the sharpest hit as AI–cap-ex financing math came under the microscope.
September headline CPI printed +3.7% YoY, hotter than consensus and the warmest reading of the year, with Bank of America noting 55% of the core basket running above a 2.5% annualized three-month pace. Shelter and services inflation stayed sticky; goods disinflation cooled.
The reaction across rates was immediate: the 10-year yield firmed to ~5.10% (the 30-year near 5.42%), curve flattening resumed, and traders cut the probability of an October hike from ~33% intraweek to ~15% by Friday — still leaving roughly one quarter-point hike priced into year-end. The dollar firmed; growth-sensitive assets wobbled.
The “last mile” of disinflation remains unfinished. With oil pushing back toward $110 on Hormuz escalation and tariffs re-entering the discourse, the probability of a renewed inflation impulse into Q1 2027 is non-trivial. We model Fed pause as the base case, with hike risk back on the table.
What began as isolated chatter about hyperscaler capex payback hardened this week into a measurable risk-off move in AI infrastructure. CoreWeave (CRWV) was the fulcrum: shares shed ~12% as its 2029 secured notes yielded above 15%, implying genuine credit stress for a benchmark Nvidia-backed data-center operator. The SOXX semiconductor ETF printed a ninth-straight down session, its worst eight-session stretch since April 2025.
Yet the fabrication layer told a different story. TSMC posted record Q3 revenue of T$1.49 trillion (~$46.7B, +50% YoY), beating both consensus and its own prior guidance range. September revenue alone was +54.6% YoY. The read-through: demand at the silicon workbench remains structurally healthy; the stress is at the monetization and financing layer above it — which is exactly where valuations stretch thinnest.
Software and cloud (SaaS, hyperscalers) outperformed chips modestly intraweek before giving it back Friday. Meta −3.7%, Netflix −2.9%, Microsoft −1.8%, Palantir ~−7%. Nvidia's print now carries unusual weight — a decisive beat with upward Blackwell/Rubin visibility could reset positioning; a soft tone would validate the funding anxiety.
| Name | WoW |
|---|---|
| CRWV CoreWeave | −11.9% |
| PLTR Palantir | −7.0% |
| META Meta Platforms | −3.7% |
| NFLX Netflix | −2.9% |
| TSLA Tesla | −2.1% |
| MSFT Microsoft | −1.8% |
| TSM TSMC (ADR) | +1.8% |
With Iran escalating in the Strait of Hormuz and the Trump administration's China rhetoric intensifying, the defense complex absorbed capital from rotating tech money. Pentagon modernization budgets remain upwardly skewed, and four of the five large primes (LMT, NOC, RTX, GD) are consistently raising dividends on long-tail backlogs.
Lockheed Martin (LMT) extended its uptrend as munitions replenishment, F-35 sustainment and hypersonic funding feed through to orders. Shipbuilders and electronic-warfare names continued to find premium multiples. Shielded by multi-year contracts, this cohort behaves closer to utilities than to cyclicals — a feature in a late-cycle, risk-off tape.
Our defense factor basket flipped to “Overweight” on Tuesday as our geopolitical-stress composite crossed the 70th percentile. Fundamental: book-to-bill > 1.1 across the top four primes; relative strength vs. S&P: +7.8% over 90 days.
| Name | WoW |
|---|---|
| LMT Lockheed Martin | +3.1% |
| RTX RTX Corp. | +2.6% |
| NOC Northrop Grumman | +2.2% |
| GD General Dynamics | +1.9% |
| LHX L3Harris | +1.4% |
| HII Huntington Ingalls | +1.1% |
| LDOS Leidos | +0.9% |
The S&P 500 Health Care sector (XLV) hit a record high intraweek, led by large-cap pharma, device makers and managed care rebounding off defensive-rotation flows. Beneath the index, biotech dispersion remained extreme: the XBI biotech ETF is +23% YTD while mega-cap single names like Moderna (MRNA) are up ~600% YTD, with the melanoma vaccine partnership with Merck re-rating the pipeline since August's Phase 3 readout. MRNA did finish the week lower (~−9%) on profit-taking into the medical-meeting data later this month.
Deal activity continues to concentrate at the obesity/metabolic frontier and “molecular glue” chemistry. Roche has announced five China-biotech deals worth $5B+ since late August; GSK and AstraZeneca have each run similar playbooks for 20+ months.
Our takeaway: the market is paying real option value for binary clinical events, but only where the data is unambiguous. Mid-cap biotech still trades like a correlation trade to credit spreads — which widened this week.
| Name | WoW |
|---|---|
| LLY Eli Lilly | +4.2% |
| UNH UnitedHealth | +3.1% |
| JNJ Johnson & Johnson | +2.3% |
| VRTX Vertex Pharma | +1.9% |
| REGN Regeneron | +1.5% |
| XBI SPDR Biotech ETF | −0.8% |
| MRNA Moderna | −9.0% |
| Bank | Revenue | Net Income | Diluted EPS | Notable |
|---|---|---|---|---|
| JPM JPMorgan Chase |
$50.2B | $15.3B | $5.57 | $5.75 ex-securities loss; dividend/buyback intact |
| GS Goldman Sachs |
$18.7B | $5.3B | $17.01 | Trading, investment banking both strong |
| MS Morgan Stanley |
$20.3B | $4.9B | $3.03 | Wealth management ~$6T AUM milestone |
| C Citigroup |
$23.8B | $5.2B | $2.85 | EPS +53% YoY; markets & services led |
| WFC Wells Fargo |
$21.9B | $6.0B | $1.87 | NIM stable; expense discipline |
| BAC Bank of America |
$30.0B | $6.9B | $0.91 | $1.08 adj. after $1.2B regulatory charge |
Across the six, record trading revenue (volatility harvest), reserve releases on consumer credit, and resilient fee lines offset slower loan growth and higher deposit costs. The group ended the week green, with Financials (XLF) one of three positive S&P sectors.
Gold spot touched a record $4,079.70/oz and closed near $4,075 (+1.4% on Friday alone), carried by renewed U.S.-China tariff rhetoric, central-bank buying and ETF inflows. YTD gold is +53%. Silver kissed a record $51.70/oz before easing; both metals print RSIs in the 80s — stretched, but momentum intact.
In energy, Brent spiked to $110 intraweek on Iran-Hormuz escalation, with WTI nearing $100. Oil's bid is both geopolitical and inflationary — a key crosswind for the Fed path and a tailwind for XLE.
The dollar firmed modestly on hot CPI and yield support, though gains were muted by safe-haven competition from precious metals. The yen weakened past 155/USD as the BoJ held, pressuring Asian risk assets. The euro was flat to a touch softer vs. USD.
Crypto was mixed in a classic de-risk week: Bitcoin held around $81,600 (−0.5% Friday, roughly flat on the week), finding support at the 200-day. Ethereum underperformed, with the ETH/BTC ratio drifting lower. XRP and select large caps continued to drive weekly ETF inflow headlines.
Headline reporters next week include Netflix, Tesla, IBM, Verizon, Coca-Cola, Johnson & Johnson, Procter & Gamble, General Motors, Boeing, Lockheed Martin, and additional regional banks. Credit guidance tone across industrials will matter more than top-line beats; defense primes' order books are the proxy for 2027 Pentagon flow.
The AI narrative pivot date is Nvidia's print in three weeks — any supplier color (optics, HBM, substrates, power) in the next two weeks can precondition positioning.
Monday: Fed speakers (Williams, Jefferson) · Tuesday: Existing home sales · Wednesday: Fed Beige Book · Thursday: Weekly jobless claims, S&P flash PMIs (manufacturing, services) · Friday: UMich consumer sentiment (final), durable goods proxy.
FOMC decision is October 28–29: current pricing favors a hold, but any Fed-speak lean this coming week could meaningfully reprice the December path. The 10-year's defense of 5.10% is the key technical anchor.